IPO
149
|
106
Biopharmaceutical company GlobeImmune files for a $69
GlobeImmune, a developer of therapeutic drugs for cancer and infectious diseases, filed on Tuesday with the SEC to raise up to $69 million in an initial public offering. The company has four product candidates in five ongoing clinical trials.The Louisville, CO-based company has two strategic collaborations, one with Celgene for all oncology related product candidates and the other with Gilead Sciences for
